High variability in baseline urinary free cortisol values in patients with Cushing's disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary: Objective: Twenty‐four‐hour urinary free cortisol (UFC) sampling is commonly used to evaluate Cushing's syndrome. Because there are few data on UFC variability in patients with active Cushing's disease, we analysed baseline UFC in a large patient cohort with moderate‐to‐severe Cushing's disease and assessed whether variability correlates with hypercortisolism severity. These data will help clinicians establish the minimum number of UFC samples required to obtain reliable data. Design: Observational study (enrolment phase of Phase III study). Methods: Patients (n = 152) with persistent/recurrent or de novo Cushing's disease and mean UFC (mUFC) ≥1·5×ULN (normal: 30–145 nmol/24 h) were included. Mean UFC level was calculated from four 24‐h urine samples collected over 2 weeks. Results: Over 600 24‐h UFC samples were analysed. The mUFC levels of samples 1 and 2 and samples 3 and 4 were 1000 nmol/24 h (SD 1872) and 940 nmol/24 h (SD 2148), respectively; intrapatient coefficient of variation (CV) was 38% for mUFC. The intrapatient CV using all four samples was 52% (95% CI: 48–56). The intrapatient CV was 51% (95% CI: 44–58) for samples 1 and 2, 49% (95% CI: 43–56) for samples 3 and 4 and 54% (95% CI: 49–59) for samples 1, 2 and 3. Variability in mUFC increased as UFC levels increased. There were no correlations between UFC and clinical features of hypercortisolism. Conclusions: There is intrapatient variability of approximately 50% in 24‐h UFC measurements, which is relevant to targets set to estimate any treatment effect. Analysing more than two 24‐h collection periods in individual patients does not result in a relevant decrease in variability. Interestingly, UFC levels did not correlate with hypercortisolism severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 3×
“9 A systematic review and meta-analysis of the literature on diagnostic tests for Cushing’s syndrome showed that UFC and overnight DST have the most evidence to support their use, although the receiver operator characteristic curves for UFC were slightly inferior to those for DST. 10 Despite…”
InfluentialSelf-citationA 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
Self-citationMorbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Gender-Related Differences in the Presentation and Course of Cushing’s Disease
Giraldi, F. P., Moro, M., & Cavagnini, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021518 · Cited by 260 · cited 1×
“27 Additional studies are therefore required to assess whether there is indeed a negative correlation between urinary creatinine and UFC levels.”
Accuracy of Diagnostic Tests for Cushing’s Syndrome: A Systematic Review and Metaanalyses
Elamin, M. B., Murad, M. H., Mullan, R., Erickson, D., Harris, K., Nadeem, S., Ennis, R., Erwin, P. J., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0139 · Cited by 222 · cited 2×
“…have the most evidence to support their use, although the receiver operator characteristic curves for UFC were slightly inferior to those for DST. 10 Despite shortcomings, UFC measurements are often used in medical practice to diagnose Cushing’s disease, to assess for remission after pituitary…”
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Godbout, A., Manavela, M., Danilowicz, K., Beauregard, H., Bruno, O. D., & Lacroix, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0382 · Cited by 202 · cited 1×
“8,11,12 The reliability and reproducibility of this test are very important.”
Viardot, A., Huber, P., Puder, J. J., Zulewski, H., Keller, U., & Müller, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2264 · Cited by 172 · cited 1×
“Although the reproducibility of late-night salivary cortisol has been measured previously, 21 to our knowledge, this is the first such analysis of the intrapatient variance of 24-h UFC measurements.”
Research works printed but not linked: 22
- 10.1016/j.beem.2009.06.001 · DOI · Paper page
- 10.1016/S0140-6736(06)68699-6 · DOI · Paper page
- 10.1210/jc.2010-1942 · DOI · Paper page
- 10.1530/EJE-07-0762 · DOI · Paper page
- 10.1210/jc.2006-2112 · DOI · Paper page
- 10.7326/0003-4819-130-10-199905180-00015 · DOI · Paper page
- 10.1210/jc.2009-0612 · DOI · Paper page
- 10.1210/jc.2008-1533 · DOI · Paper page
- 10.1056/NEJM199109263251301 · DOI · Paper page
- 10.1111/j.1365-2265.1993.tb00341.x · DOI · Paper page
- 10.1093/clinchem/43.8.1386 · DOI · Paper page
- 10.2307/2532835 · DOI · Paper page
- Besemer F., 2011, Alcohol‐induced Cushing syndrome. Hypercortisolism caused by alcohol abuse, The Netherlands Journal of Medicine, 69, 318
- Invitti C., 1991, Increased urinary free cortisol and decreased serum corticosteroid‐binding globulin in polycystic ovary syndrome, Acta Endocrinologica (Copenhagen), 125, 28
- Vierhapper H., 1990, Metabolism of cortisol in anorexia nervosa, Acta Endocrinologica (Copenhagen), 122, 753
- 10.1097/00006842-200111000-00018 · DOI · Paper page
- 10.1159/000029054 · DOI · Paper page
- 10.1007/BF03350337 · DOI
- 10.7326/0003-4819-101-3-334 · DOI · Paper page
- 10.2165/00003088-200342070-00003 · DOI
- 10.1097/00019616-199803000-00001 · DOI · Paper page
- 10.1210/jc.2003-030234 · DOI · Paper page
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationCushing's syndrome: update on signs, symptoms and biochemical screening
Nieman, L. K. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0464 · Cited by 343
Cushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210
“UFC values in Cushing’s syndrome are variable.(64,65) Cushing’s syndrome is highly unlikely in the setting of three or more normal UFC levels, except in rare cases of cyclic Cushing’s syndrome.”
Long-term cortisol measures predict Alzheimer disease risk
Ennis, G. E., An, Y., Resnick, S. M., Ferrucci, L., O'Brien, R. J., & Moffat, S. D. (2017) · Neurology · doi:10.1212/wnl.0000000000003537 · Cited by 151
“Within-person UFC/Cr variability was calculated with a previously used method: UFC/Cr variability 5 antilog (within-person SD on the log scale) 2 1.(13) Covariates.”
MethodCushing’s syndrome: from physiological principles to diagnosis and clinical care
Raff, H., & Carroll, T. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282871 · Cited by 137
Metadata
- Authors
- Petersenn, S., Newell‐Price, J., Findling, J. W., Gu, F., Maldonado, M., Sen, K., Salgado, L. R., Colao, A., Biller, B. M. K., & Pasireotide B2305 Study Group
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2013-07-15
- Volume
- 80
- Issue
- 2
- Pages
- 261-269
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2029724540
- Cited by
- 150
- References
- 7
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.